OverviewRetatrutide is an investigational triple-agonist peptide studied for its activity across GLP-1, GIP, and glucagon receptor pathways in metabolic research. Research FocusResearch applications include multi-receptor pathway modeling and incretin signaling integration studies. Mechanism of InterestIts multi-agonist profile enables exploration of receptor crosstalk and coordinated intracellular pathway activation. Compliance NoticeFor research only. Not for human consumption.